Medication info

Q-Dine Tablet (Ranitidine Hydrochloride)

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›168mg / 1 tablet
Manufacturer / importer
AlboGen Korea Co., Ltd.
Appearance
White, round, film-coated tablet
Packaging
100 tablets (10 tablets/PTP x 10), 150 tablets (10 tablets/PTP x 15)
Approval status
Expired

MFDS item code 200403321 · Notified 2004.03.10

This product's status changed to Expired on 2025.04.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (such as ulcers); improvement of gastric mucosal lesions; prevention of Mendelson syndrome
Who takes it
Adults · Children
Adult dose
Administer 150 mg orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 150 mg of this medicine orally twice daily, or 300 mg once daily at bedtime. A higher cure rate may be achieved, particularly in patients with duodenal ulcers, by administering 300 mg twice daily, in the morning and at bedtime. The dosage is the same for concomitant treatment to prevent ulcers caused by nonsteroidal anti-inflammatory drugs or gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks; conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 8 weeks, although healing may take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 150 mg of this medicine twice daily for 8 weeks, or 300 mg once daily before bedtime. For patients with severe reflux esophagitis, the dose may be increased to 150 mg four times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 150 mg of this medicine three times daily, and increase as needed. In severe cases, up to 6 g daily may be administered as directed by a physician. 4) For upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions, treatment is usually initiated with an injection. Once oral administration is possible, switch to oral administration and give 150 mg of this medicine twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 150 mg of this medicine 2 hours before induction of anesthesia. It is preferable to also administer 150 mg on the evening before surgery. 6) Improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Administer 150 mg of this medicine once daily at bedtime. 3. Patients with renal impairment For patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the plasma concentration of the medicine; therefore, adjust the dosing schedule immediately after hemodialysis. Adjust the dose as appropriate according to age and symptoms.
Child dose
For patients aged 12 years and older, administer 75 mg of this medicine orally twice daily (for oral solution only). For ages 8 〜 18 years, up to 150 mg (2 mg per kg of body weight) may be administered twice daily.

Ingredients

Manufacturer
AlboGen Korea Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (such as ulcers); improvement of gastric mucosal lesions; prevention of Mendelson syndrome

  • Gastric and duodenal ulcers
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • post-surgical ulcers
  • gastric and duodenal ulcers due to non-steroidal anti-inflammatory drug administration
  • gastric mucosal lesions
  • acute gastritis
  • exacerbation of chronic gastritis
  • upper gastrointestinal bleeding
  • peptic ulcers
  • acute stress ulcers
View approved original text

This medication is used for various gastrointestinal diseases such as gastric and duodenal ulcers, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also taken before anesthesia to prevent Mendelson's syndrome and is effective for ulcers that may occur post-surgery and for gastric damage caused by non-steroidal anti-inflammatory drugs. It helps improve gastric mucosal lesions such as recurrent and chronic gastritis exacerbation and upper gastrointestinal bleeding. The liquid formulation is also used to alleviate heartburn and sour eructation symptoms due to excess gastric acid. Overall, it is a very useful medication for protecting the gastric mucosa and treating ulcers and inflammation.

How to take

Adult dose

Administer 150 mg orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 150 mg of this medicine orally twice daily, or 300 mg once daily at bedtime. A higher cure rate may be achieved, particularly in patients with duodenal ulcers, by administering 300 mg twice daily, in the morning and at bedtime. The dosage is the same for concomitant treatment to prevent ulcers caused by nonsteroidal anti-inflammatory drugs or gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks; conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 8 weeks, although healing may take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 150 mg of this medicine twice daily for 8 weeks, or 300 mg once daily before bedtime. For patients with severe reflux esophagitis, the dose may be increased to 150 mg four times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 150 mg of this medicine three times daily, and increase as needed. In severe cases, up to 6 g daily may be administered as directed by a physician. 4) For upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions, treatment is usually initiated with an injection. Once oral administration is possible, switch to oral administration and give 150 mg of this medicine twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 150 mg of this medicine 2 hours before induction of anesthesia. It is preferable to also administer 150 mg on the evening before surgery. 6) Improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Administer 150 mg of this medicine once daily at bedtime. 3. Patients with renal impairment For patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the plasma concentration of the medicine; therefore, adjust the dosing schedule immediately after hemodialysis. Adjust the dose as appropriate according to age and symptoms.

Child dose

For patients aged 12 years and older, administer 75 mg of this medicine orally twice daily (for oral solution only). For ages 8 〜 18 years, up to 150 mg (2 mg per kg of body weight) may be administered twice daily.

Precautions

This medication should not be taken by individuals allergic to this medication or its components. People with a rare disease known as acute porphyria may also experience worsening symptoms if they take this medication, so they should avoid it. Individuals with a hereditary condition that prevents lactose digestion should not take this medication due to the lactose it contains. Caution is needed for those with poor kidney function, as this medication may accumulate in the body, leading to increased blood concentration; dosage should be reduced or intervals between doses increased. Those with weakened liver function should also use this medication carefully. Individuals with a history of drug allergies should be cautious when taking this medication. Elderly individuals should take care, as body functions may be impaired. When using non-steroidal anti-inflammatory drugs concurrently, especially in the elderly or in those with a history of peptic ulcers, regular monitoring is required. This medication may mask symptoms of gastric cancer, so those with gastric ulcers or individuals over middle age displaying new dyspeptic symptoms should confirm whether there is a malignant condition before taking it. Patients with gastric or duodenal ulcers infected with Helicobacter pylori should also receive bacterial treatment. Though rare, severe allergic reactions or shock can occur with this medication; if any unusual symptoms appear, discontinue use immediately and go to a hospital. If allergic symptoms such as hives, rash, or respiratory distress occur, stop taking the medication and seek medical advice. If any symptoms of blood abnormalities such as fatigue, bleeding, or fever appear, blood tests are necessary; if abnormalities are found, discontinue the medication. If symptoms of liver dysfunction or jaundice occur, discontinue the medication immediately. Circulatory problems such as arrhythmias or vasculitis can also occur, although rarely, so caution is warranted. Gastrointestinal symptoms such as constipation, nausea, abdominal pain may occur, and in severe cases, consult medical personnel immediately. Reports have also mentioned neurological symptoms such as dizziness, drowsiness, headaches, and confusion; if these symptoms occur, discontinue use and consult a doctor. Endocrine symptoms such as gynecomastia and erectile dysfunction have also been reported, albeit rarely. For musculoskeletal issues such as myalgia or rhabdomyolysis, stop taking the medication and seek medical advice. Skin-related symptoms such as rashes or hair loss may also occur infrequently. During treatment, the condition of the disease should be checked frequently, and the minimum effective dose should be administered; if no effect is observed, a change in treatment should be considered. Elderly patients or those with chronic lung disease or diabetes may have an increased risk for pneumonia, so caution is warranted. If dizziness or drowsiness occurs, avoid driving or operating dangerous machinery. This medication may interact with other drugs, affecting their efficacy or side effects. Especially when taken alongside anticoagulants, frequent checks of blood coagulation status are necessary. Some drugs may interfere with excretion or may impact absorption due to decreased gastric acid secretion, so any concurrent medications should be discussed with a physician or pharmacist. Pregnant women or women who might become pregnant should take this medication cautiously as its safety has not been established and should only be taken when necessary. Breastfeeding mothers should also be cautious, as this medication can pass into breast milk and should only be taken if essential. Safety in children has not been fully established, so caution is needed for pediatric use. The elderly should be cautious about dosage adjustments, as decreased kidney function may lead to prolonged medication retention in the body. Taking this medication may yield false positive results in certain tests, so attention should be paid to test methods. Overdosage is rarely associated with serious issues, but symptomatic treatment like vomiting or gastric lavage may be necessary, and in some cases, dialysis may be required. This medication should be kept out of reach of children, and transferring it to another container should be avoided as it may compromise quality and pose a risk of accidents. Prolonged use may lead to increased bacterial growth in the gastrointestinal tract due to decreased gastric acid secretion, so caution is warranted. Additionally, animal studies suggest the medication may accumulate in ocular tissues, so regular ophthalmologic examinations are advised during extended use.

Side effects

  • Anaphylactic shock
  • urticaria
  • angioedema
  • rash
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • elevated serum creatinine
Show 59 more
  • leukopenia
  • thrombocytopenia
  • aplastic anemia
  • pure red cell aplasia
  • refractory anemia
  • agranulocytosis
  • pancytopenia
  • acquired immune hemolytic anemia
  • eosinophilia
  • general malaise
  • weakness
  • subcutaneous bleeding
  • mucosal bleeding
  • fever
  • liver dysfunction
  • jaundice
  • hepatitis
  • bradycardia
  • atrioventricular block
  • tachycardia
  • vasculitis
  • constipation
  • nausea
  • vomiting
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • diarrhea
  • acute pancreatitis
  • dizziness
  • drowsiness
  • seizures
  • headache
  • heaviness in the head
  • insomnia
  • agitation
  • anxiety
  • confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorder
  • consciousness disorder
  • liver-type muscle spasms
  • gynecomastia
  • galactorrhea
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • skin rash
  • erythema multiforme
  • alopecia
  • stomatitis
  • skin itching
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius. Proper storage can help maintain the effectiveness of the medication.

Appearance and packaging

Appearance

White, round, film-coated tablet

Package unit

100 tablets (10 tablets/PTP x 10), 150 tablets (10 tablets/PTP x 15)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.